David Veenstra

6PUBLICATIONS
33CO-AUTHORS
Cancer geneticsMolecular targetsPredictive and prognostic markersBehavioural epidemiologyGenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 17, 2026
Public attitudes toward cascade genetic screening in the United States.

|Jan 23, 2024
The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations.

William Wong, Stacey Kowal, Tu My To

|Aug 30, 2023
Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study.

Boya Guo, Sarah Knerr, Tia L Kauffman

|May 08, 2022
Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung Cancer.

Woojung Lee, William B Wong, Stacey Kowal

|Aug 18, 2020
Provider preferences for resolving uncertainty and avoiding harms in precision medicine: a discrete choice experiment.

Nathaniel Hendrix, Dean A Regier, Jagori Chatterjee

|Jul 16, 2019
Cost-effectiveness of population genomic screening.

David L Veenstra, Greg Guzauskas, Josh Peterson

Pageof 1

Frequent Collaborators

2 joint publications

Meng Li

2 joint publications

William Wong

2 joint publications

Stacey Kowal

2 joint publications

Louis P Garrison